Chowdhury Muhammad MD is categorized under Infectious Disease Specialists in Newburgh, NY and active since 1999.
Chowdhury Muhammad MD was established in 1999, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Infectious Disease Specialists business, which does work in the B2C market, and is classified as a Infectious Disease Specialists, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Muhammad Chowdhury at the company’s single location by writing to 327 Fullerton Avenue, Newburgh, New York NY 12550 or by phoning (845) 561-4032. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Chowdhury Muhammad MD |
| Contact Person: | Muhammad Chowdhury |
| Address: | 327 Fullerton Avenue, Newburgh, New York 12550 |
| Phone Number: | (845) 561-4032 |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Founded: | 1999 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Infectious Disease Specialists |
| SIC Code: | 8011 |
| NAICS Code: | 6211110 |
| Share This Business: |
Chowdhury Muhammad MD was started in 1999 to provide professional Infectious Disease Specialists under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Muhammad Chowdhury for inquiries that concern Chowdhury Muhammad MD by calling the company number (845) 561-4032, as your correspondence is most welcome. Additionally, the physical location of the single location of Chowdhury Muhammad MD can be found at the coordinates 41.51323,-74.02523 as well as the street address 327 Fullerton Avenue in Newburgh, New York 12550.
For its online presence, you may visit Chowdhury Muhammad MD’s website at and engage with its social media outlets through on Twitter and on Facebook.